Arthritis drug tocilizumab can help critically-ill Covid patients recover, trial finds

Patients given the drug in the REMAP-CAP trial, led by Imperial College London, were 87 per cent more likely to see their illness improve than those not given the drug.

from Health News | Mail Online https://ift.tt/3pKtm6I